1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine

C80H99Cl3N18O9S2 — CID 158301224

IUPAC1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
SMILESCN(C)C(=O)C1CCCN(c2cc(Cl)cc3[nH]ncc23)C1.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.Cc1cc(N2CCN(S(C)(=O)=O)C[C@H]2C)c2cn[nH]c2c1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.OC1(c2ccccc2)CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C18H18ClN3O.C17H24N4O3S.C16H18ClN3O2.C15H19ClN4O.C14H20N4O2S/c19-14-10-16-15(12-20-21-16)17(11-14)22-8-6-18(23,7-9-22)13-4-2-1-3-5-13;1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;1-19(2)15(21)10-4-3-5-20(9-10)14-7-11(16)6-13-12(14)8-17-18-13;1-10-6-13-12(8-15-16-13)14(7-10)18-5-4-17(9-11(18)2)21(3,19)20/h1-5,10-12,23H,6-9H2,(H,20,21);10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);6-8,10H,3-5,9H2,1-2H3,(H,17,18);6-8,11H,4-5,9H2,1-3H3,(H,15,16)/t;;;;11-/m....1/s1
InChIKeyGMNDHKYNAIFNBG-PXAOQQMGSA-N
MW1627.28 g/mol
LogP11.67
Rot. Bonds11

About 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine

1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine (PubChem CID 158301224) has the molecular formula C80H99Cl3N18O9S2 and a molecular weight of 1627.28 g/mol. Its IUPAC name is 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine.

Molecular Properties

Compound Name1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
PubChem CID158301224
Molecular FormulaC80H99Cl3N18O9S2
Molecular Weight1627.28 g/mol
Exact Mass1624.63
IUPAC Name1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
SMILESCN(C)C(=O)C1CCCN(c2cc(Cl)cc3[nH]ncc23)C1.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.Cc1cc(N2CCN(S(C)(=O)=O)C[C@H]2C)c2cn[nH]c2c1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.OC1(c2ccccc2)CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C18H18ClN3O.C17H24N4O3S.C16H18ClN3O2.C15H19ClN4O.C14H20N4O2S/c19-14-10-16-15(12-20-21-16)17(11-14)22-8-6-18(23,7-9-22)13-4-2-1-3-5-13;1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;1-19(2)15(21)10-4-3-5-20(9-10)14-7-11(16)6-13-12(14)8-17-18-13;1-10-6-13-12(8-15-16-13)14(7-10)18-5-4-17(9-11(18)2)21(3,19)20/h1-5,10-12,23H,6-9H2,(H,20,21);10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);6-8,10H,3-5,9H2,1-2H3,(H,17,18);6-8,11H,4-5,9H2,1-3H3,(H,15,16)/t;;;;11-/m....1/s1
InChIKeyGMNDHKYNAIFNBG-PXAOQQMGSA-N
XLogP11.67
TPSA310.43 Ų
H-Bond Donors6
H-Bond Acceptors18
Rotatable Bonds11
Heavy Atoms112
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001627.28
LogP ≤ 511.67
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1018

Analyze 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The IUPAC name of 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine (CID 158301224) is 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine.
What is the SMILES notation for 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The canonical SMILES for 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine is CN(C)C(=O)C1CCCN(c2cc(Cl)cc3[nH]ncc23)C1.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.Cc1cc(N2CCN(S(C)(=O)=O)C[C@H]2C)c2cn[nH]c2c1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.OC1(c2ccccc2)CCN(c2cc(Cl)cc3[nH]ncc23)CC1.
What is the InChIKey of 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The InChIKey is GMNDHKYNAIFNBG-PXAOQQMGSA-N. The full InChI is InChI=1S/C18H18ClN3O.C17H24N4O3S.C16H18ClN3O2.C15H19ClN4O.C14H20N4O2S/c19-14-10-16-15(12-20-21-16)17(11-14)22-8-6-18(23,7-9-22)13-4-2-1-3-5-13;1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;1-19(2)15(21)10-4-3-5-20(9-10)14-7-11(16)6-13-12(14)8-17-18-13;1-10-6-13-12(8-15-16-13)14(7-10)18-5-4-17(9-11(18)2)21(3,19)20/h1-5,10-12,23H,6-9H2,(H,20,21);10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);6-8,10H,3-5,9H2,1-2H3,(H,17,18);6-8,11H,4-5,9H2,1-3H3,(H,15,16)/t;;;;11-/m....1/s1.
What are the key properties of 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine has a molecular weight of 1627.28 g/mol, XLogP of 11.67, 11 rotatable bonds, 6 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(6-chloro-1H-indazol-4-yl)-N,N-dimethylpiperidine-3-carboxamide;1-(6-chloro-1H-indazol-4-yl)-4-phenylpiperidin-4-ol;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-methyl-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine is sourced from PubChem (CID 158301224), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).